Intraluteal Infusions of Prostaglandins of the E, D, I, and A Series Prevent PGF2α-Induced, but Not Spontaneous, Luteal Regression in Rhesus Monkeys1

Authors:
  • RSR. L. Stouffer
    R. L. Stouffer

Abstract
A luteotropic role for prostaglandins (PGs) during the luteal phase of the menstrual cycle of rhesus monkeys was suggested by the observation that intraluteal infusion of a PG synthesis inhibitor caused premature luteolysis. This study was designed to identify PGs that promote luteal function in primates. First, the effects of various PGs on progesterone (P) production by macaque luteal cells were examined in vitro. Collagenase-dispersed luteal cells from midluteal phase of the menstrual cycle (Day 6-7 after the estimated surge of LH, n = 3) were incubated with 0-5 000 ng/ml PGE2, PGD2, 6.beta.PGI, (a stable analogue of PGI2), PGA2, or PGF2.alpha. alone or with hCG (100 ng/ml). PGE2, PGD2, and 6.beta.PGI1 alone stimulated (P < 0.05) P production to a similar extent (2- to 3-fold over basal) as hCG alone, whereas PGA2 and PGF2.alpha. alone no effect on production. Stimulation (p < 0.05) of P synthesis by PGE2, PGD2, and 6.beta.PGI1 in combination with hCG was similar to that of hCG alone. Whereas PGA2 inhibited gonadotropin-induced P production (P < 0.05), that in the presence of PGF2.alpha. plus hCG (p = 0.05) to remain elevated. Second, the effects of various PGs on P production during chronic infusion into the CL were studied in vivo. Saline with or without 0.1% BSA (n = 12), PGE2 (300 ng/h; n = 4), PGD2 (300 ng/h; n = 4), 6.beta.PGI1 (500 ng/h; n = 3), PGA2 (300 ng/h; n = 4), or PGF2.alpha. (10 ng/h; n = 8) was infused via osmotic minipump beginning at m midluteal phase (Days 5-8 after the estimated LH surge) until menses. In addition, the same dose of PGE, PGD, PGI, or PGA was infused in combination with PGF2.alpha. (n = 3-4/group) for 7 days. P levels over 5 days preceding treatment were not different among groups. In 5 of 8 monkeys receiving PGF2.alpha. alone, P declined to <0.5 ng/ml within 72 h after initiation of infusion and was lower (p < 0.05) than controls. The length of the luteal phase in PGF2.alpha.-infused monkeys was shortened (12.3 .+-. 0.9 days; mean .+-. SEM, n = 8; p < 0.05) compared to controls (15.8 .+-. 0.5). Intraluteal infusion of PGE, PGD, PGI, or PGA alone did not affect patterns of circulating P or luteal phase length. In contrast, intraluteal infusion of PGE, PGD, or PGA in combination with PGF2.alpha. maintained P levels during the infusion period and prevented the premature menses seen with infusion of PGF2.alpha. alone. Although P levels were consistently lower than controls during 3 days after initiation of 6.beta.PGI2.alpha. plus PGF2.alpha. infusion, luteal phase length in these monkeys was similar to controls. Thus, PGs that stimulate steroidogenesis in vitro will prevent premature luteolysis induced by exogenous PGF2.alpha., but will not prevent timely luteolysis in spontaneous menstrual cycles in monkeys. Although PGA2 was antigonadotropic in vitro, it did not suppress luteal function in vivo, but counteracted the luteolytic effect of exogenous PGF2.alpha.

This publication has 31 references indexed in Scilit: